英科医疗（300677）：全球丁腈手套龙头周期复苏与进阶之路：百尺竿头，更进一步

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [5][9]. Core Insights - The company is a leading manufacturer of disposable gloves, particularly nitrile gloves, and has significantly expanded its production capacity from 19 billion units in 2019 to 56 billion units by mid-2025, establishing itself as a global leader in the nitrile glove market [1][15]. - The nitrile glove industry is experiencing robust demand due to its superior performance and low allergy rates, with global rubber glove demand projected to reach approximately 325 to 375 billion units by 2025, maintaining a strong growth trend [1][40]. - The company has built a strong cost advantage through technological leadership, self-supply of raw materials, and economies of scale, making it difficult for competitors to replicate its cost structure [2][47]. Company Overview - The company generates over 90% of its revenue from medical protective products, primarily nitrile and PVC gloves, with a significant portion of its sales coming from overseas markets, particularly North America and Europe [20][31]. - The management team is stable, with key executives having extensive experience in manufacturing, supply chain management, and international sales [27][30]. Industry Analysis - The nitrile glove market is characterized by a high-quality price ratio, with increasing penetration in various applications beyond medical use, driven by heightened public health awareness [31][36]. - The supply structure is dominated by manufacturers from Malaysia and China, with the demand primarily concentrated in the U.S. and Europe, which account for about 60% of global consumption [44][45]. Financial Projections - The company is expected to achieve revenues of 10.01 billion, 12.56 billion, and 14.48 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 5.15%, 25.41%, and 15.34% [11][9]. - The net profit forecast for the same period is projected to be 1.26 billion, 1.71 billion, and 2.19 billion yuan, reflecting growth rates of -14.1%, 36.2%, and 27.9% [11][9].